Chidozie Ugwumba reports 9.7% stake in Clene Inc. (CLNN)

Rhea-AI Filing Summary

Clene Inc. ownership disclosure: Chidozie Ugwumba reports beneficial ownership of 1,351,071 shares of Common Stock, representing 9.7% of the class. The reported total includes 176,713 issued shares and 1,174,358 shares issuable upon immediately exercisable warrants (Tranche A, Tranche B, and a Common Stock Purchase Warrant). The filing cites 12,778,307 shares outstanding as of May 14, 2026 from the company’s Form 10-Q.

The Schedule 13G/A lists sole voting and dispositive power over all reported shares. The filing is an ownership update signed by the reporting person on 05/15/2026.

Insights

Governance Expert

Holder crosses 5% reporting threshold with exercisable warrants included.

The filing shows 1,351,071 shares (9.7%) beneficially owned, combining issued shares and immediately exercisable warrants: 176,713 issued, 375,000 Tranche A, 375,000 Tranche B, and 424,358 Common Stock Purchase Warrant. The ownership figure is anchored to May 14, 2026 outstanding shares reported in a Form 10-Q.

Voting and dispositive power are reported as sole for the entire position. Future filings will show whether warrants are exercised; current cash‑flow treatment is not stated in the excerpt.

Securities Compliance Analyst

Schedule 13G/A used for passive/beneficial ownership disclosure.

The amendment identifies the filing as a Schedule 13G/A ownership amendment and supplies a detailed breakdown of instruments underlying the 9.7% stake. It cites the issuer’s Form 10-Q for the 12,778,307 shares outstanding anchor.

Confirmatory steps: review subsequent Forms 4/5 or registration statements if the reporting person activates exercises or converts warrants; the excerpt does not state any recent transfers or sales.

Key Figures

Beneficial ownership: 1,351,071 shares Percent of class: 9.7% Issued shares included: 176,713 shares +4 more

7 metrics

Beneficial ownership 1,351,071 shares Amount beneficially owned reported on Schedule 13G/A

Percent of class 9.7% Percent of Common Stock reported in the filing

Issued shares included 176,713 shares Part of the 1,351,071 total identified in the comment

Tranche A warrants 375,000 shares Shares issuable upon exercise of Tranche A Warrants (immediately exercisable)

Tranche B warrants 375,000 shares Shares issuable upon exercise of Tranche B Warrants (immediately exercisable)

Common Stock Purchase Warrant 424,358 shares Shares issuable upon exercise of the Purchase Warrant (immediately exercisable)

Shares outstanding 12,778,307 shares Company's outstanding Common Stock per cited Form 10-Q (as of May 14, 2026)

Key Terms

Schedule 13G/A, immediately exercisable warrants, beneficially owned, dispositive power

4 terms

Schedule 13G/A regulatory

"Amendment No. 3) Clene Inc. Common Stock ... Schedule 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

immediately exercisable warrants financial

"shares of Common Stock issuable upon exercise of Tranche A Warrants that are immediately exercisable"

beneficially owned regulatory

"Amount beneficially owned: 1,351,071 (b) Percent of class: 9.7%"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 1,351,071"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 02:56 PM Learn about SEC filing dates

FAQ

What stake does Chidozie Ugwumba report in CLNN?

Mr. Ugwumba reports beneficial ownership of 1,351,071 shares, equal to 9.7% of Clene Inc.'s Common Stock according to the Schedule 13G/A filing.

How is the 1,351,071 share total composed in the filing?

The total includes 176,713 issued Common Stock and 1,174,358 shares issuable upon exercise of immediately exercisable warrants (Tranche A, Tranche B, and a Purchase Warrant).

What shares‑outstanding figure does the filing cite for CLNN?

The filing references 12,778,307 shares outstanding as of May 14, 2026, as represented in the issuer's Form 10-Q that is cited in the Schedule 13G/A.

Does the filing indicate voting or dispositive power over the shares?

Yes; the Schedule 13G/A reports sole voting power of 1,351,071 shares and sole dispositive power of 1,351,071 shares for the reporting person.

Are the warrants immediately exercisable according to the filing?

Yes; the filing states the Tranche A, Tranche B, and the Common Stock Purchase Warrant are immediately exercisable and are included in the beneficial ownership total.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Clene Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G8959N130

(CUSIP Number)

05/11/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G8959N130

1

Names of Reporting Persons

Ugwumba Chidozie

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,351,071.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,351,071.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,351,071.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.7 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: With regard to the number of shares reported in response to (5), (7), and (9) above, the number represents (i) 176,713 shares of Common Stock of the Issuer, (ii) 375,000 shares of Common Stock issuable upon exercise of Tranche A Warrants that are immediately exercisable, (iii) 375,000 shares of Common Stock issuable upon exercise of Tranche B Warrants that are immediately exercisable, and (iv) 424,358 shares of Common Stock issuable upon exercise of the Common Stock Purchase Warrant that is immediately exercisable. The foregoing is based on 12,778,307 shares of the Issuer's Common Stock issued and outstanding, as represented in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 14, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Clene Inc.
(b)	Address of issuer's principal executive offices: 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UTAH, 84121.
Item 2.
(a)	Name of person filing: Chidozie Ugwumba
(b)	Address or principal business office or, if none, residence: c/o SymBiosis Capital Management, LLC 609 SW 8th St., Suite 510, Bentonville, AR 72712
(c)	Citizenship: United States of America
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: G8959N130
Item 4.	Ownership
(a)	Amount beneficially owned: 1,351,071
(b)	Percent of class: 9.7%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,351,071
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,351,071
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Ugwumba Chidozie

Signature:	/s/ Chidozie Ugwumba
Name/Title:	Reporting Person
Date:	05/15/2026